PhRMA

PhRMA Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from PhRMA, Medical and health, 670 Maine Avenue SW Ste. 1000, Washington D.C., DC.

We represent America’s innovative biopharmaceutical research & biotechnology companies, advocating for policies that support the discovery of new medicines and ensure broad patient access to safe, effective treatments.

Growing America's biopharmaceutical manufacturing base means growing opportunity.Since 2015, biopharmaceutical manufactu...
08/12/2026

Growing America's biopharmaceutical manufacturing base means growing opportunity.

Since 2015, biopharmaceutical manufacturing employment has increased by 24%, reflecting continued investment in the people, facilities and communities that power medical innovation.

https://ow.ly/ZTNf50ZyWbo

08/11/2026

August is National Immunization Awareness Month.

Vaccines have transformed public health, helping protect generations of Americans from preventable diseases. Every American should be able to protect themselves and their family with vaccines without barriers getting in the way.

Learn more in our latest issue brief: https://ow.ly/T74u50ZyBRN

08/08/2026

Community Servings is a food and nutrition program that makes meals tailored to patients’ medical needs – and investments made by Takeda have allowed them to innovate even further to help patients.

Local partnerships like this demonstrate how biopharmaceutical companies are committed to transforming the patient experience and the positive impact this has on entire communities.

https://ow.ly/M1ew50ZxKeE

08/07/2026

Every potential medicine teaches researchers something.

Hundreds, even thousands, of molecules are evaluated before just a handful advance to clinical trials, and most never become approved medicines. Each step adds to our scientific understanding, helping researchers refine future approaches and build on what they've learned.

Scientific progress is driven by discovery, persistence and the knowledge gained along the way.

Melanie from Merck breaks it down.

🚨 The IRA promised better access. The data tells a different story. Nearly 1 in 4 patients trying to start a medicine su...
08/06/2026

🚨 The IRA promised better access. The data tells a different story.

Nearly 1 in 4 patients trying to start a medicine subject to the IRA's price controls was initially denied in the first quarter of 2026, according to a new IQVIA analysis.

The takeaway? Coverage doesn't always mean access. Even with Medicare coverage requirements in place, many patients—especially those with cancer and immune diseases—continued to face significant insurer-imposed barriers to treatment.

Policymakers should reject policies that expand price controls and instead focus on improving patient access.



08/05/2026

Every potential new medicine begins with years of research and testing.

Bringing a medicine from the laboratory to patients takes 10 to 15 years, requires significant investment and carries a high risk of failure. Yet every clinical trial moves science forward and helps researchers better understand the next generation of treatments.

Supporting medical innovation means supporting the research – and the people – that make future breakthroughs possible.

Hear more from Carolyn, who works in clinical development for Kite, A Gilead Company.

08/04/2026

CEO of Takeda, Julie Kim, talks about how real innovation can happen not only in medicine, but also in the communities where biopharmaceutical companies make their home.

https://ow.ly/mxB850Zwh7M

National Immunization Awareness Month is an opportunity to recognize the critical role vaccines play in preventing serio...
08/03/2026

National Immunization Awareness Month is an opportunity to recognize the critical role vaccines play in preventing serious disease – and the lasting value they deliver for families, communities and the U.S. economy. The impact is significant:

- Routine childhood vaccination for those born between 1994 and 2023 is projected to prevent more than 500 million cases of illness, 32 million hospitalizations and more than 1 million deaths, saving in turn roughly – $540 billion in direct costs to patients and $2.7 trillion is cost to society.

- Every $1 invested in vaccination generates an estimated $17.80 in benefits for taxpayers and public budgets.

Learn more about how vaccines help protect Americans from disease while reducing costs and strengthening the U.S. economy:

https://ow.ly/73Lo50ZvNJW

Did you know? 42% of biopharmaceutical manufacturing jobs are in technical and skills-based roles, accessible through ce...
07/29/2026

Did you know? 42% of biopharmaceutical manufacturing jobs are in technical and skills-based roles, accessible through certificates, apprenticeships and two-year degrees.

Behind every breakthrough is a skilled workforce helping manufacture medicines, strengthen America's innovation economy and improve the lives of patients.

https://ow.ly/PRVm50Zuk58

The biopharmaceutical industry develops new treatments and cures for complex diseases while working to ensure patient ac...
07/27/2026

The biopharmaceutical industry develops new treatments and cures for complex diseases while working to ensure patient access and affordability. Since 2000, it has delivered over 850 new medicines for debilitating and devastating illnesses such as cancer, heart disease, neurodegenerative conditions and rare diseases, saving lives, improving quality of life and extending survival. With over 8,000 innovative medicines in development, America's strong intellectual property protections continue to fuel groundbreaking treatment advances.

Address

670 Maine Avenue SW Ste. 1000
Washington D.C., DC
20024

Telephone

+12028353400

Website

Alerts

Be the first to know and let us send you an email when PhRMA posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to PhRMA:

Shortcuts

Featured

Share

Category